2017 Section 7 Green Book

Review Clinical Review & Education

Use of FDG-PET/CT in Oropharyngeal Squamous Cell Carcinoma

40 . Kim SY, Lee SW, Nam SY, et al. The feasibility of 18F-FDG PET scans 1 month after completing radiotherapy of squamous cell carcinoma of the head and neck. J Nucl Med . 2007;48(3):373-378 . 41 . Porceddu SV, Pryor DI, Burmeister E, et al. Results of a prospective study of positron emission tomography-directed management of residual nodal abnormalities in node-positive head and neck cancer after definitive radiotherapy with or without systemic therapy. Head Neck . 2011;33(12):1675-1682 . 42 . Fakhry C, Zhang Q, Nguyen-Tan PF, et al. Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma. J Clin Oncol . 2014;32(30):3365-3373 . 43 . Chen AY, Vilaseca I, Hudgins PA, Schuster D, Halkar R. PET-CT vs contrast-enhanced CT: what is the role for each after chemoradiation for advanced oropharyngeal cancer? Head Neck . 2006;28(6): 487-495 . 44 . Ng SH, Chan SC, Yen TC, et al. PET/CT and 3-T whole-body MRI in the detection of malignancy in treated oropharyngeal and hypopharyngeal carcinoma. Eur J Nucl Med Mol Imaging . 2011;38(6): 996-1008 . 45 . Koshkareva Y, Branstetter BF IV, Gaughan JP, Ferris RL. Predictive accuracy of first posttreatment PET/CT in HPV-related oropharyngeal squamous cell carcinoma. Laryngoscope . 2014;124(8):1843-1847. 46 . Moon SH, Choi JY, Lee HJ, et al. Prognostic value of 18F-FDG PET/CT in patients with squamous cell carcinoma of the tonsil: comparisons of volume-based metabolic parameters. Head Neck . 2013;35(1):15-22 . 47 . Alluri KC, Tahari AK, Wahl RL, Koch W, Chung CH, Subramaniam RM. Prognostic value of FDG PET metabolic tumor volume in human papillomavirus-positive stage III and IV oropharyngeal squamous cell carcinoma. AJR Am J Roentgenol . 2014;203(4):897-903 . 48 . Cheng NM, Fang YH, Chang JT, et al. Textural features of pretreatment 18F-FDG PET/CT images: prognostic significance in patients with advanced T-stage oropharyngeal squamous cell carcinoma. J Nucl Med . 2013;54(10):1703-1709 . 49 . Cheng NM, Chang JT, Huang CG, et al. Prognostic value of pretreatment ¹⁸ F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma. Eur J Nucl Med Mol Imaging . 2012;39(11):1673-1684 . 50 . Kikuchi M, Koyasu S, Shinohara S, et al. Prognostic value of pretreatment 18 F-fluorodeoxyglucose positron emission tomography/CT volume-based parameters in patients with oropharyngeal squamous cell carcinoma with known p16 and p53 status. Head Neck . 2015;37(10):1524-1531.

oropharynx carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod . 2009;108(6):933-938 . 19 . Kovács AF, Döbert N, Gaa J, Menzel C, Bitter K. Positron emission tomography in combination with sentinel node biopsy reduces the rate of elective neck dissections in the treatment of oral and oropharyngeal cancer. J Clin Oncol . 2004;22(19): 3973-3980 . 20 . Wallowy P, Diener J, Grünwald F, Kovács AF. 18F-FDG PET for detecting metastases and synchronous primary malignancies in patients with oral and oropharyngeal cancer. Nuklearmedizin . 2009;48(5):192-199 . 21 . Chan SC, Wang HM, Yen TC, et al. ¹⁸ F-FDG PET/CT and 3.0-T whole-body MRI for the detection of distant metastases and second primary tumours in patients with untreated oropharyngeal/ hypopharyngeal carcinoma: a comparative study. Eur J Nucl Med Mol Imaging . 2011;38(9):1607-1619 . 22 . Hujala K, Sipilä J, Grenman R. Panendoscopy and synchronous second primary tumors in head and neck cancer patients. Eur Arch Otorhinolaryngol . 2005;262(1):17-20 . 23 . Krabbe CA, Pruim J, Dijkstra PU, et al. 18F-FDG PET as a routine posttreatment surveillance tool in oral and oropharyngeal squamous cell carcinoma: a prospective study. J Nucl Med . 2009;50(12): 1940-1947 . 24 . van der Haring IS, Schaapveld MS, Roodenburg JL, de Bock GH. Second primary tumours after a squamous cell carcinoma of the oral cavity or oropharynx using the cumulative incidence method. Int J Oral Maxillofac Surg . 2009;38(4):332- 338 . 25 . Haerle SK, Strobel K, Hany TF, Sidler D, Stoeckli SJ. 18 F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma. Head Neck . 2010;32(3):319-325 . 26 . Morris LG, Sikora AG, Patel SG, Hayes RB, Ganly I. Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer. J Clin Oncol . 2011;29(6):739-746 . 27 . Gan SJ, Dahlstrom KR, Peck BW, et al. Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers. Cancer . 2013;119(14):2593-2601 . 28 . Rodriguez-Bruno K, Ali MJ, Wang SJ. Role of panendoscopy to identify synchronous second primary malignancies in patients with oral cavity and oropharyngeal squamous cell carcinoma. Head Neck . 2011;33(7):949-953 . 29 . Subramaniam RM, Agarwal A, Colucci A, Ferraro R, Paidpally V, Mercier G. Impact of concurrent diagnostic level CT with PET/CT on the utilization of stand-alone CT and MRI in the

management of head and neck cancer patients. Clin Nucl Med . 2013;38(10):790-794 . 30 . Kovalchuk N, Jalisi S, Subramaniam RM, Truong MT. Deformable registration of preoperative PET/CT with postoperative radiation therapy planning CT in head and neck cancer. Radiographics . 2012;32(5):1329-1341 . 31 . Chatterjee S, Frew J, Mott J, et al. Variation in radiotherapy target volume definition, dose to organs at risk and clinical target volumes using anatomic (computed tomography) versus combined anatomic and molecular imaging (positron emission tomography/computed tomography): intensity-modulated radiotherapy delivered using a tomotherapy Hi Art machine: final results of the VortigERN study. Clin Oncol (R Coll Radiol) . 2012;24(10):e173-e179 . 32 . Troost EG, Bussink J, Hoffmann AL, Boerman OC, Oyen WJ, Kaanders JH. 18F-FLT PET/CT for early response monitoring and dose escalation in oropharyngeal tumors. J Nucl Med . 2010;51(6): 866-874 . 33 . Subramaniam RM, Truong M, Peller P, Sakai O, Mercier G. Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer. AJNR Am J Neuroradiol . 2010;31(4):598- 604 . 34 . Menda Y, GrahamMM. Update on 18F-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers. Semin Nucl Med . 2005;35(4):214-219 . 35 . Paulino AC, Koshy M, Howell R, Schuster D, Davis LW. Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys . 2005;61(5):1385-1392 . 36 . Ciernik IF, Dizendorf E, Baumert BG, et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. Int J Radiat Oncol Biol Phys . 2003;57(3):853-863 . 37 . Marcus C, Ciarallo A, Tahari AK, et al. Head and neck PET/CT: therapy response interpretation criteria (Hopkins criteria)—interreader reliability, accuracy, and survival outcomes. J Nucl Med . 2014; 55(9):1411-1416 . 38 . Isles MG, McConkey C, Mehanna HM. A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy. Clin Otolaryngol . 2008;33(3):210-222 . 39 . Sjövall J, Brun E, Almquist H, Kjellén E, Wahlberg P. Radiotherapy response in head and neck cancer—evaluation of the primary tumour site. Acta Otolaryngol . 2014;134(6):646-651 .

(Reprinted) JAMA Otolaryngology–Head & Neck Surgery January 2016 Volume 142, Number 1

jamaotolaryngology.com

Copyright 2016 American Medical Association. All rights reserved.

49